13F-HR 1 r02-1231.txt 13F HOLDINGS REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: December 31, 2002 Check here if Amendment [ ]; Amendment No.: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Rho Capital Partners, Inc. Address: 152 West 57th Street 23rd Floor New York, New York 10019 13F File Number: 28-5883 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Peter E. Kalkanis Title: Chief Financial Officer Phone: 212-751-6677 /s/ Peter E. Kalkanis New York, New York Dated: February 13, 2003 Report Type (Check only one.): [X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. I AM SIGNING THIS REPORT AS REQUIRED BY THE SECURITIES EXCHANGE ACT OF 1934. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form 13F Information Table Entry Total: 27 Form 13F Information Table Value Total: $65,223 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE Value Shares/ Sh/ Put/ Invstmt Other Voting Authority Name of Issuer Title of Class CUSIP (x$1000) PrnAmt Prn Call Discret Mngrs Sole Shared None 3-D PHARMACEUTICALS COM 88554W104 8,284 2,564,579 SH Sole 2,564,579 ACTIVE POWER INC COM 00504W100 1,484 833,669 SH Sole 833,669 AGERE SYS INC CL B 00845V209 149 106,516 SH Sole 106,516 AIRSPAN NETWORKS INC COM 00950H102 1,465 1,510,253 SH Sole 1,510,253 AVANT IMMUNOTHER COM 053491106 1,021 899,954 SH Sole 899,954 BIOTRANSPLANT INC COM 09066Y107 367 816,337 SH Sole 816,337 CAPSTONE TURBINE CORP COM 14067D102 1,818 2,019,453 SH Sole 2,019,453 CHIQUITA BRNDS INT INC COM 170032809 300 22,662 SH Sole 22,662 CISCO SYS INC COM 17275R102 132 10,107 SH Sole 10,107 COMMERCE ONE INC DEL COM 200693109 274 99,727 SH Sole 99,727 CYBERONICS INC COM 23251P102 19,453 1,057,239 SH Sole 1,057,239 DIACRIN INC COM 25243N103 1,849 1,694,867 SH Sole 1,694,867 DIVERSA CORP COM 255064107 14,834 1,639,153 SH Sole 1,639,153 DYAX CORP COM 26746E103 512 284,616 SH Sole 284,616 FIDELITY NTL SOLUTNS COM 31620P109 579 33,542 SH Sole 33,542 GENAERA CORP COM 36867G100 168 261,890 SH Sole 261,890 GENZYME-BIOSURGERY COM 372917708 66 25,801 SH Sole 25,801 GENZYME-MOLECULAR COM 372917500 202 115,265 SH Sole 115,265 IVILLAGE INC COM 46588H105 1,572 1,672,319 SH Sole 1,672,319 LUCENT TECHNLOGIES COM 549463107 507 402,614 SH Sole 402,614 MILLENNIUM PHARMACTLS COM 599902103 138 17,388 SH Sole 17,388 MISSION RESOURCES CORP COM 605109107 547 1,334,409 SH Sole 1,334,409 ONESOURCE INFO SVCS COM 68272J106 2,823 368,065 SH Sole 368,065 QUOVADX INC COM 74913K106 152 62,686 SH Sole 62,686 SILICON LABORATORIES COM 826919102 1,909 100,076 SH Sole 100,076 VERSICOR INC COM 925314106 4,523 419,230 SH Sole 419,230 VIROPHARMA INC COM 928241108 95 64,804 SH Sole 64,804